Skip to main content
California Medicine logoLink to California Medicine
. 1962 Feb;96(2):109–111.

EFFECT OF AMPHETAMINES ON SPEECH DEFECTS IN THE MENTALLY RETARDED

Charles H Fish, Evelyn Bowling
PMCID: PMC1574858  PMID: 13893193

Abstract

In a double-blind study, 106 mentally retarded patients with speech defects were given 15 mg. of d-Amphetamine daily, or a placebo, for a three-month period. Speech defect types were: Stuttering, immature production, oral inaccuracy, lisp, psychotic, mongoloid, aphasia, deafness, and cleft palate. Only the stutterers showed obvious improvement in comparison with the placebo group. Three severe, long-term stutterers showed such dramatic improvement that their whole course in life has been changed.

Full text

PDF
110

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. GINN S. A., HOHMAN L. B. The use of dextro-amphetamine in severe behavior problems of children. South Med J. 1953 Nov;46(11):1124–1127. doi: 10.1097/00007611-195311000-00019. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES